Incidence of cancer in a population-based cohort of patients with type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 3, Issue 1, 2009, Pages 12-16

  Ulcickas Yood, Marianne ^a,b   Oliveria, Susan A ^a,c   Campbell, Ulka B ^a   Koro, Carol E ^d  

^a EpiSource   (United States)

^b YALE CANCER CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Cancer incidence; Cancer risk; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER CANCER; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 62649093923     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.10.003     Document Type: Article

References (50)

1. Centers for Disease Control, National Diabetes Surveillance System.
2. Swerdlow A.J., Laing S.P., Qiao Z., and Slater S.D. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92 (2005) 2070-2075
3. Adami H.O., McLaughlin J., Ekbom A., and Berne C. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2 (1991) 307-314
4. Balkau B., Barrett-Connor E., Eschwege E., and Richard J.L. Diabetes and pancreatic carcinoma. Diabetes Metab 19 (1993) 458-462
5. Calle E.E., Murphy T.K., Rodriguez C., and Thun M.J. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9 (1998) 403-410
6. Chow W.H., Gridley G., Nyren O., and Linet M.S. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 87 (1995) 930-931
7. Everhart J., and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. J Am Med Assoc 273 (1995) 1605-1609
8. Gullo L., Pezzilli R., and Morselli-Labate A.M. Diabetes and the risk of pancreatic cancer, Italian Pancreatic Cancer Study Group. N Engl J Med 331 (1994) 81-84
9. La Vecchia C., Negri E., Franceschi S., and D'Avanzo B. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70 (1994) 950-953
10. Adami H.O., Chow W.H., Nyren O., and Berne C. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88 (1996) 1472-1477
11. Fujino Y., Mizoue T., Tokui N., and Yoshimura T. Prospective study of diabetes mellitus and liver cancer in Japan. Diabet/Metab Res Rev 17 (2001) 374-379
12. Hassan M.M., Hwang L.Y., Hatten C.J., and Swaim M. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36 (2002) 1206-1213
13. La Vecchia C., Negri E., Decarli A., and Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73 (1997) 204-207
14. Lagiou P., Kuper H., Stuver S.O., and Tzonou A. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 92 (2000) 1096-1099
15. Kravchick S., Gal R., Cytron S., and Peled R. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res 7 (2001) 56-59
16. La Vecchia C., D'Avanzo B., Negri E., and Franceschi S. History of selected diseases and the risk of colorectal cancer. Eur J Cancer 27 (1991) 582-586
17. La Vecchia C., Negri E., Decarli A., and Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 6 (1997) 1007-1010
18. Coughlin S.S., Calle E.E., Teras L.R., and Petrelli J. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159 (2004) 1160-1167
19. Kabat G.C., Dieck G.S., and Wynder E.L. Bladder cancer in nonsmokers. Cancer 57 (1986) 362-367
20. Larsson S.C., Orsini N., Brismar K., and Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49 (2006) 2819-2823
21. Larsson S.C., Orsini N., and Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97 (2005) 1679-1687
22. Keku T.O., Lund P.K., Galanko J., and Simmons J.G. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2076-2081
23. Khaw K.T., Wareham N., Bingham S., and Luben R. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 13 (2004) 915-919
24. Michaud D.S., Liu S., Giovannucci E., and Willett W.C. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 94 (2002) 1293-1300
25. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36 (2000) 1224-1228
26. Risch H.A. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 95 (2003) 948-960
27. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., and Barzi F. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92 (2005) 2076-2083
28. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Hormone Metab Res 35 (2003) 694-704
29. Bergmann U., Funatomi H., Yokoyama M., and Beger H.G. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55 (1995) 2007-2011
30. Singh P., and Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology 105 (1993) 1218-1237
31. Yang S., Lin H.Z., Hwang J., and Chacko V.P. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?. Cancer Res 61 (2001) 5016-5023
32. Oliveria SA, Koro CE, Ulcickas Yood M, The risk of cancer associated with antidiabetic therapy: a retrospective cohort study, The American Diabetes Association Annual Meeting June 11, 2006, Washington, DC. .
33. Cooper G.S., Yuan Z., Stange K.C., and Dennis L.K. The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care 37 (1999) 436-444
34. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Databases: Incidence - SEER 13 Regs Public-Use, November 2004 Sub for Expanded Races (1992-2002) and Incidence - SEER 13 Regs excluding AK Public-Use, November 2004 Sub for Hispanics (1992-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
35. El-Serag H.B., Richardson P.A., and Everhart J.E. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 96 (2001) 2462-2467
36. Wideroff L., Gridley G., Mellemkjaer L., and Chow W.H. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 (1997) 1360-1365
37. El-Serag H.B., Hampel H., and Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4 (2006) 369-380
38. DeMeo M.T. Pancreatic cancer and sugar diabetes. Nutr Rev 59 (2001) 112-115
39. Fisher W.E. Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease?. World J Surg 25 (2001) 503-508
40. Inoue M., Tajima K., Takezaki T., and Hamajima N. Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 32 (2003) 257-262
41. Ng Y., Husain I., and Waterfall N. Diabetes mellitus and bladder cancer-an epidemiological relationship?. Pathol Oncol Res 9 (2003) 30-31
42. Risch H.A., Burch J.D., Miller A.B., and Hill G.B. Dietary factors and the incidence of cancer of the urinary bladder. Am J Epidemiol 127 (1988) 179-191
43. Tripathi A., Folsom A.R., and Anderson K.E. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 95 (2002) 2316-2323
44. Albanes D., and Winick M. Are cell number and cell proliferation risk factors for cancer?. J Natl Cancer Inst 80 (1988) 772-774
45. Kirkpatrick C.S., White E., and Lee J.A. Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 139 (1994) 869-880
46. Lukanova A., Bjor O., Kaaks R., Lenner P., Lindahl B., Hallmans G., et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 118 (2006) 458-466
47. Thune I., Olsen A., Albrektsen G., and Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway. Int J Cancer 55 (1993) 555-561
48. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabet Care 27 (2004) 1047-1053
49. Hu F.B., Manson J.E., Liu S., and Hunter D. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91 (1999) 542-547
50. Le Marchand L., Wilkens L.R., Kolonel L.N., and Hankin J.H. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57 (1997) 4787-4794